Beer M, Eble M J, Wannenmacher M, Staehler G
Abteilung Urologie, Chirurgische Universitätsklinik Heidelberg.
Urologe A. 1994 Mar;33(2):110-5.
The efficacy of radiotherapy of renal cell carcinomas is limited by its side effects. To avoid gastrointestinal problems the dose must not exceed 45 Gy, but with corresponding protocols no effect has been seen in curative and adjuvant trials. A new three-step protocol combining surgery with intraoperative radiotherapy focussed on the tumor bed fading out the intestine (IORT) and external boost radiotherapy (40 Gy) was used in six patients with local recurrences after tumor nephrectomy. No increase in morbidity was induced by IORT. One year after radiotherapy no recurrences have been seen in the radiation field. We recommend this protocol for patients with solitary local recurrences and for tumors of clinical stage T3 and T4.
肾癌放疗的疗效受其副作用限制。为避免胃肠道问题,剂量不得超过45 Gy,但采用相应方案在根治性和辅助性试验中未见效果。一种新的三步方案,即手术联合术中针对肿瘤床的放疗(使肠道避开)及体外增强放疗(40 Gy),应用于6例肾切除术后局部复发的患者。术中放疗未导致发病率增加。放疗一年后,放疗区域未见复发。我们推荐该方案用于孤立性局部复发患者以及临床分期为T3和T4期的肿瘤患者。